Assistance Publique Hôpitaux de Paris
selects Bruker's mass spectrometry biotyper
10 Dec 2010
The Assistance Publique Hôpitaux de Paris (APHP) has selected
Bruker's IVD MALDI Biotyper as their MALDI-TOF mass spectrometry-based
microbial identification tool.
APHP is the association of all 44 public hospitals in Paris, and is
the largest public health network in France. It provides a medical
service for the complete metropolitan area of Paris.
As a result of this selection, the three Hospitals Bichat, Cochin
and Lariboisière have each already ordered an IVD MALDI Biotyper
system. Additionally, the Hospitals Necker and Pitié-Salpétrière had
previously selected and have already been working with Bruker's
MALDI-TOF mass spectrometers for several years.
The APHP hospitals will use the IVD MALDI Biotyper for mass
spectrometry-based identification of microorganisms, such as
gram-negative bacteria, gram-positive bacteria and yeasts. Due to
typically much faster time-to-result (TTR) and lower consumables
cost, MALDI Biotyper-based microbial identification is currently
increasingly replacing classical biochemical identification
approaches. In fact, MALDI Biotyper molecular identification is
almost as specific as sequence-based ‘gold standard’ identification,
and allows the rapid identification of most bacterial species within
minutes.
Dr. Martin Rottman, Associate Professor of Microbiology at
University of Versailles and Hospital Raymond Poincaré, Garches
pointed out: “We want to use MALDI-TOF mass spectrometry
identification in routine clinical microbiology applications to
achieve the precision in bacterial identification that could
otherwise only be obtained using time-consuming sequence based
identification.
"Indeed the currently available biochemical methods fail to
identify many micro-organisms involved in bone and joint infections.
The setup of the ISMABIOs regional network for the surveillance and
treatment of bone and joint infection, jointly funded by the Region
Ile de France through the DIM Malinf program and AP-HP, the hospital
of Versailles and the hospital Croix Saint Simon will use MALDI-TOF
based bacterial identification to achieve rapid and exact microbial
identification in this demanding task.
"Bruker’s MALDI Biotyper was selected as an obvious choice
because it is the only platform with CE-IVD marking and the only
system currently validated for clinical use in Europe. Moreover, the
instrument can be connected to the laboratory information system for
defined IVD applications, as well as be used as an open, research
oriented, development platform.”
Mr Peio Mogabure, Microbiology Business Development Manager at
Bruker Daltonique S.A., added: “Our selection by the APHP hospital
association is a major milestone for further establishing the IVD
MALDI Biotyper as the standard mass spectrometry tool in routine
laboratories for microbial identification in France. During the last
two years, we have successfully implemented the technology at
several university hospitals. With this selection, our market
leading position for MALDI-TOF mass spectrometry based microbial
identification is further underpinned.”
The MALDI Biotyper is available for research use only.